glp 1 and asthma The Role of GLP-1 Analogues in the Treatment of Obesity-Related Phenotype GLP‑1 Asthma: Can These Drugs
Description
16, 2021, for cases of acute cholecystitis associated with GLP-1 use
As a practical starting point, products with minimal added sugars (around 5 grams or less per serving) may be preferable for most patients
In the SURMOUNT 1 trial, tirzepatide 15 mg/wk with general nutritional instructions produced a 20.9 % reduction in body weight from baseline (versus 3.1 % with general nutrition instructions alone) [15], whereas in the SURMOUNT 3 trial, tirzepatide 10 or 15 mg/wk started after 12 weeks of intensive lifestyle intervention produced a 25 % reduction from baseline (versus 4.8 % with intensive lifestyle intervention alone) [170]
Keeping this perspective protects people from misplaced hope
Genetic predisposition testing is optional but may provide useful context
